Depression is a significant public health problem, but its etiology and pathophysiology remain poorly understood. Such incomplete understanding likely arises from the fact that depression encompasses a heterogeneous set of disorders. To overcome these limitations, renewed interest in intermediate phenotypes (endophenotypes) has resurfaced, and anhedonia has emerged as one of the most promising endophenotypes of depression. Here, a heuristic model is presented postulating that anhedonia arises from dysfunctional interactions between stress and brain reward systems. To this end, we review and integrate three bodies of independent literature investigating the role of (a) anhedonia, (b) dopamine, and (c) stress in depression. In a fourth section, we summarize animal data indicating that stress negatively affects mesocorticolimbic dopaminergic pathways critically implicated in incentive motivation and reinforcement learning. In the last section, we provide a synthesis of these four literatures, present initial evidence consistent with our model, and discuss directions for future research. 
INTRODUCTION
Despite its "ignominious status as a world leader in burden of disease" (Greden 2001, p. 30) and decades of research, the etiology and pathophysiology of major depressive disorder (MDD) remain largely unknown. This lack of understanding partially stems from issues inherent in current classification systems, which define mental illness based on clusters of symptoms and clinical course rather than etiology or pathophysiology (Hyman 2007) . As a consequence, the diagnosis of MDD, although reliable, might lack validity and encompass a heterogeneous set of disorders with distinct pathophysiologies.
To overcome these limitations, a focus on narrowly defined and quantifiable phenotypes, often referred to as "endophenotypes," has been advocated. According to Gottesman & Gould (2003) , endophenotypes provide "a means for identifying the 'downstream' traits [. . .] of clinical phenotypes, as well as the 'upstream' consequences of genes" (p. 637). In this conceptualization, intermediate phenotypes are assumed to be positioned within the causal chain between genes and disease and thus represent a more proximal expression of biological and environmental influences than a syndrome. To be considered an endophenotype, a construct should meet the following criteria (Gottesman & Gould 2003) : (a) specificity (i.e., the endophenotype is more strongly linked to a given condition than other psychiatric conditions) 1 ; (b) heritability; (c) state independence (i.e., the endophenotype is stable over time and independent from illness status and treatment); (d ) cosegregation (i.e., the endophenotype occurs more frequently in affected, compared to evidence suggesting that MDD is characterized by blunted transmission of dopamine (DA), the neurotransmitter most consistently linked to reward processing (link B). Next, we briefly discuss studies emphasizing the pivotal role stress plays in the emergence, maintenance, and exacerbation of depression, including work indicating that early adversities increase vulnerability to depression and stress sensitivity later in life (link C). An explicit link between stress and anhedonic behavior is made in the fourth section, based on nonhuman animal data indicating that stress negatively affects mesocorticolimbic dopaminergic pathways (link D). In the final section, we provide a synthesis of these four literatures, present initial evidence consistent with our model, and discuss limitations of the current literature and future directions.
THE ROLE OF ANHEDONIA IN DEPRESSION
To facilitate integration between human and nonhuman animal findings, the following section is restricted to studies using laboratory-based measures of hedonic behavior and reinforcement learning. Due to space limitations, we limit our review to behavioral and neuroimaging studies in MDD.
Behavioral Studies
Studies assessing perceptual/attentional processes. Over the past decades, a multitude of studies have focused on putative abnormalities in the early stage of information processing, including at the perceptual and attentional level, but these studies have generally failed to paint a consistent pattern of abnormalities in MDD.
Perceptual tasks. Evidence is mixed for impaired perceptual processing of positive stimuli in MDD. In face recognition studies, depressed subjects recognized happy facial expressions more slowly (e.g., Suslow et al. 2004 ) and less accurately (e.g., Persad & Polivy 1993) than did controls, but numerous studies have failed to replicate these findings (e.g., Leppanen et al. 2004) . Moreover, global recognition impairments extending to other facial expressions have been described, highlighting a lack of specificity (e.g., Persad & Polivy 1993) .
A generally neglected aspect in these early studies might explain some of the inconsistencies. Because these studies assess only accuracy and reaction time, they cannot address whether deficits might be confounded by response biases. Three studies examined this issue. Using signal-detection analyses, Surguladze et al. (2004) reported that subjects with MDD showed a response bias away from happy expressions. In the second study, relative to controls, subjects with MDD identified fewer neutral faces as happy and more neutral faces as sad, demonstrating a negative processing bias and a lack of positivity bias (Gollan et al. 2008) . Finally, using morphed facial expressions, Joormann & Gotlib (2006) described that subjects with MDD required greater intensity of emotional expression in order to identify happy-but not sad-faces relative to controls ( Joormann & Gotlib 2006) . These findings emerged within the framework of no overall group differences in accuracy. Together, these findings suggest that face recognition dysfunctions might stem from cognitive biases rather than perceptual dysfunctions.
Attentional tasks. Studies investigating attentional biases in depression have yielded similarly inconsistent findings, in line with the widely assumed conceptualization that MDD is characterized by impairments in elaborative, rather than attentional, processes (Williams et al. 1997) . In contrast with this general assumption, some studies using the deployment-of-attention and dot-probe tasks, in which an emotional and a neutral stimulus compete for attentional resources, suggest that MDD may be linked to attentional biases away from positive cues.
In the deployment-of-attention task, participants are presented with an emotional and a neutral word, which are then replaced by two color bars; participants are instructed to select whichever bar appeared first. Because the two bars are presented simultaneously, preference for the bar replacing a positive word is taken as an indication that attention was captured by the positive word. Unlike healthy controls, who display a positivity bias (i.e., they attend relatively more to positive stimuli) or a protective bias (i.e., they direct attention away from negative stimuli), depressed subjects perform this task in an unbiased fashion (e.g., Gotlib et al. 1988 , Wang et al. 2006 . Interestingly, remitted depressed subjects showed a positivity bias and/or avoidance of negative stimuli under normal conditions (McCabe et al. 2000 , Wang et al. 2006 ) but show a lack of bias after a sad mood induction (McCabe et al. 2000) .
In a study using a dot-probe paradigm, in which a neutral and an emotional facial expression are presented concurrently, both currently and formerly depressed subjects selectively attended to sad faces and failed to attend to happy faces . Notably, a reduced bias toward happy faces (as well as an increased bias toward sad faces) was also described in neverdisordered daughters of depressed mothers after a sad mood induction ). Altogether, these findings raise the possibility that blunted attentional biases toward positive cues is a trait marker associated with increased vulnerability to depression.
Studies assessing encoding and retrieval. Evidence for weaker affective responses to positive cues at encoding in depression has emerged from studies investigating affective and behavioral responses to a variety of positive stimuli, although inconsistencies abound. When exposed to such stimuli, depressed subjects generally showed (a) reduced positive affect and arousal (e.g., Berenbaum & Oltmanns 1992 , Rottenberg et al. 2002 , Sloan et al. 2001 cf. Dichter et al. 2004) and (b) diminished behavioral (e.g., facial) responsiveness (e.g., Berenbaum & Oltmanns 1992 , Sloan et al. 2001 cf. Rottenberg et al. 2002) . In several studies, blunted affective and behavioral responses emerged for positive but not negative stimuli, highlighting a selective impairment (e.g., Berenbaum & Oltmanns 1992 , Sloan et al. 2001 .
One important question is whether decreased affective responses to positive cues might lead to impaired retrieval of such stimuli. Evidence in support of this possibility comes from early studies in which participants were asked to estimate the amount of feedback delivered during a task they had just completed. Depressed subjects were found to underestimate the frequency of positive feedback and reinforcement received and to overestimate the frequency of punishment (Nelson & Craighead 1977) .
Similar findings have emerged from studies investigating estimation of the frequency of positive outcomes in real-life settings. Among children, depressive symptoms negatively correlated with ratings of the probability of positive events happening in the future, but only when these events referred to the self (Muris & van der Heiden 2006) . Moreover, depressed subjects predicted fewer positive outcomes in the future relative to both healthy controls and individuals with anxiety disorders (e.g., Miranda & Mennin 2007) . Thus, depressed subjects' perceptions of the past are characterized by an underestimation of positive reinforcements received, whereas their view of the future is colored by a reduced expectation of positive reinforcement.
Self-referential tasks. Whereas the studies reviewed above suggest that depression is characterized by blunted affective responses to positive stimuli at encoding and impaired retrieval of positive cues, they provide little insight about whether such dysfunctions might extend to self-schemas. To address this issue, several studies have examined self-referential encoding of positive and negative adjectives in depression using the self-referent encoding task.
Early studies found increased endorsement of self-referential negative adjectives in depression (e.g., Dobson & Shaw 1987 , Serfaty et al. 2002 . More recently, evidence for reduced endorsement and recall of positive traits has emerged in currently and formerly depressed individuals (e.g., Gotlib et al. 2004) , and the proportion of endorsed positive-but not negative-words predicted depressive symptoms nine months later ( Johnson et al. 2007 ). Moreover, both remitted subjects (Ramel et al. 2007 ) undergoing a sad mood induction and currently depressed subjects (Gotlib et al. 2004 , Serfaty et al. 2002 showed reduced recall of endorsed positive traits. Of note, in the study by Dobson & Shaw (1987) , group differences after remission remained only for endorsement of positive words, raising the possibility that a reduced positive self-image might represent a vulnerability for future depressive episodes.
Similar findings have emerged from studies in pediatric samples and individuals at increased risk for depression. Reduced endorsement of positive words was observed in children of depressed mothers, but only when the self-referent encoding task was performed after a sad mood induction (Taylor & Ingram 1999) . Moreover, currently depressed-but not remitted-youths endorsed significantly fewer positive traits than did controls after a sad mood induction, whereas both depressed groups endorsed more negative traits (Timbremont & Braet 2004) . Of note, both depressed groups recalled significantly fewer positive words compared to controls. Altogether, these findings suggest that, relative to controls, depressed subjects less frequently endorse positive information as self-descriptive and show selective recall deficits for positive information, consistent with the view that elaborative processing biases are an important aspect of depression.
Tasks assessing the effects of reward manipulations. In a recognition task involving different payoff contingencies, depressed subjects showed a more conservative response bias during the reward condition relative to controls, indicating that monetary incentives failed to shift memory retrieval performance (Henriques et al. 1994) . In a probabilistic reward task involving a differential reinforcement schedule, unmedicated individuals with MDD were characterized by reduced response bias toward a more frequently rewarded stimulus (Figure 2a ; Pizzagalli et al. 2008b ). Interestingly, trial-by-trial probability analyses revealed that subjects with MDD failed to express a response bias toward the more advantageous stimulus in the absence of immediate reward. Moreover, this impairment was largest in patients reporting anhedonic symptoms and was uniquely associated with anhedonia (rather than anxiety or general distress). Notably, blunted response bias predicted MDD chronicity after eight weeks of antidepressant treatment (Vrieze et al. 2013) and persisted after full remission . Together with evidence that elevated depressive symptoms are associated with reduced reward-based decision making (Kunisato et al. 2012) , these findings indicate that depression is characterized by an impaired ability to modulate behavior as a function of reinforcement, particularly when rewards are intermittent and anhedonic symptoms are elevated. Finally, subjects with MDD were less willing than controls to expend effort in order to receive high monetary rewards (Treadway et al. 2012 ). This finding was not replicated in a study using a similar paradigm, in which individuals with MDD and healthy subjects exerted similar amounts of efforts in order to see humorous cartoons and reported similar ratings of liking; however, unlike in healthy controls, levels of reward liking did not predict motivation to expend efforts for rewards in subjects with MDD (Sherdell et al. 2012) .
Interim summary. In spite of the traditional conceptualization of anhedonia, evidence for loss of pleasure and reduced affective/behavioral responses to positive cues in depression is mixed (see also Treadway & Zald 2011) . Moreover, although a lack of positivity bias has been described in some studies probing perceptual and attentional processes, evidence for dysfunction at early stages of the information processing flow is limited. Contrary to these inconsistent findings, MDD appears to be characterized by (a) underestimation of reinforcements received and reduced Behavioral findings emerging from a probabilistic reward task involving a differential reinforcement schedule. Response bias toward the more frequently rewarded stimulus was reduced in (a) unmedicated subjects with major depressive disorder (MDD) (Pizzagalli et al. 2008b ), (b) healthy controls performing the task under an acute stressor (Bogdan & Pizzagalli 2006) , and (c) healthy controls receiving a single dose of a D2/3 agonist (pramipexole) hypothesized to reduce phasic DA signaling to reward outcomes via presynaptic DA autoreceptor activation (Pizzagalli et al. 2008a) . In each study, participants were exposed to three blocks of trials, which were used to evaluate their ability to modulate behavior as a function of the differential reinforcement schedule. expectation of future rewards, (b) less frequent endorsement and recall of positive traits in selfreferential tasks, (c) diminished ability to modulate behavior as a function of reinforcement history, (d ) reduced willingness to exert effort in order to gain reward, and (e) uncoupling between "liking" and "wanting."
Collectively, these findings provide a more nuanced understanding of anhedonia in MDD, in which motivation, reinforcement learning, and reward-based decision making-rather than the experience of pleasure per se-are impaired, and are consistent with early behavioral models postulating that depression may result from a loss of positive reinforcement (e.g., Bandura 1971) . Because positive reinforcers are stimuli that increase the likelihood of a behavior, the dysfunctions reviewed above may reduce the motivation to pursue future rewards and engage in pleasurable activities, which might in turn maintain and/or exacerbate depressive symptoms. Consistent with this hypothesis, experiential sampling studies have shown that depressed subjects engage in fewer activities associated with immediate pleasure and increased likelihood of future reward (Hopko et al. 2003) . Furthermore, anhedonia has been found to predict (a) depression two years later (Wardenaar et al. 2012) , (b) poor outcome (e.g., McMakin et al. 2012 , Spijker et al. 2001 ) even when adjusting for overall depression severity (Uher et al. 2012) , and (c) chronic course of depression over a 10-year period (Moos & Cronkite 1999) . Given these findings, it is interesting to note that behavioral treatments encouraging patients to engage in rewarding activities, reschedule activities to reintroduce positive reinforcement, and reduce avoidance have shown substantial success in alleviating depression (Ekers et al. 2008) .
In spite of convincing evidence that implicates facets of anhedonia in MDD, several important questions remain. First, very few studies have investigated whether these dysfunctions are state or trait related, and inconsistencies exist. Using self-report assessments, McFarland & Klein (2009) found that although currently depressed individuals reported reduced emotional reactivity to anticipated reward, this dysfunction was not observed in formerly depressed individuals. These findings contrast with data indicating that individuals with remitted depression show reduced (a) endorsement of positive words (Dobson & Shaw 1987) , (b) attentional bias to happy faces , and (c) ability to modulate behavior as a function of rewards . Of note, reduced endorsement of positive words (Taylor & Ingram 1999) and reduced attentional bias toward happy faces were also described in unaffected offspring of depressed mothers (after induction of a sad mood). Collectively, these findings suggest that although self-reported affective responses might normalize after symptom remission, encoding and attentional biases away from positive cues as well blunted reinforcement learning persist after remission, particularly after a mood challenge. Future studies will be required to test this hypothesis.
Second, very few studies have investigated the predictive validity of reduced reward responsiveness, but initial evidence is promising. Among MDD inpatients, blunted reward responsiveness predicted MDD chronicity eight weeks later, even when controlling for initial depression severity (Vrieze et al. 2013) . In a pediatric sample, reduced selection of high-probability, high-reward options at age 11 predicted depressive-but not anxious-symptoms at age 12 (Forbes et al. 2007) . Similarly, endorsement of positive-but not negative-words predicted greater reduction of depressive symptoms nine months later ( Johnson et al. 2007 ). Finally, among adolescent offspring of depressed parents, low reward seeking during a gambling task predicted depressive symptoms, new onset of MDD, and reduced engagement in extracurricular activities one year later, even when controlling for baseline depressive symptoms (Rawal et al. 2013 ). These findings suggest that laboratory-based tasks probing reward-related decision making might be used to identify individuals at risk for future depression, opening opportunities for intervention.
OFC: orbitofrontal cortex
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Neuroimaging Studies
A growing number of studies have investigated neural activity in response to positive cuesincluding rewards-in MDD. Broadly speaking, two general points emerge. First, across a variety of tasks probing distinct aspects of reward processing, dysfunctions in ventral (i.e., nucleus accumbens) and dorsal (i.e., caudate, putamen) striatal regions as well as orbitofrontal cortex (OFC) are among the most replicated findings. Of primary importance, and as reviewed in more detail below, these regions have been implicated in distinct aspects of reward processing. Accordingly, these studies promise to clarify which aspects of reward processing might be dysfunctional in depression. Second, these findings imply that anhedonia might be neurobiologically complex and associated with various abnormalities. In the following sections, a brief synopsis of the neural bases of incentive processing is presented, which provides a framework for interpreting findings in depression.
Functional Neuroimaging Studies of Reward Processing
Ventral striatum. A variety of findings implicate ventral striatal regions, particularly the nucleus accumbens (NAc), in coding the incentive properties of stimuli and reward prediction errors. Studies in nonhuman primates have shown that striatal DA neurons code reward-related prediction errors using phasic bursts of DA: When the animal receives an unpredicted reward, increased firing (and DA release) is seen (positive-prediction error), and learning about the behavior that led to reward is supported. Conversely, omission of an expected reward leads to transient neural (and DA) suppression (negative-prediction error), and the association between the action and outcome is weakened. Interestingly, after the animal learns that a given stimulus will be followed by a reward, this signal "travels" back in time, and DA neurons fire in response to the reward-predicting cues (Schultz 1998) .
Consistent with these animal data, functional magnetic resonance imaging (fMRI) studies have described robust activation in the human ventral striatum in response to a wide range of rewarding cues (O'Doherty 2004) . Moreover, fMRI studies have described a shift in ventral striatal activation from rewards to reward-predicting cues after associative learning has occurred (e.g., O'Doherty et al. 2004) . Finally, the ventral striatum has been found to be more strongly activated during the anticipation, rather than the consumption, of rewards (e.g., Dillon et al. 2008) . Accordingly, the ventral striatum has been strongly implicated in coding reward prediction errors and the hedonic value of outcomes, and it is robustly recruited during reward anticipation. Dorsal striatum. Similar to the NAc, putamen activation is potentiated by unexpected rewards and suppressed by omission of expected rewards, indicating that this region plays an important role in coding reward prediction errors (O'Doherty 2004) . Several findings indicate, however, that dorsal striatal regions might play a particularly strong role in reward-related learning (Delgado 2007) . Interestingly, whereas the ventral striatum has been implicated in stimulus-reward learning, the dorsal striatum appears to be mostly involved in stimulus-response-reward learning ; that is, in linking incentives to actions. Fitting this assumption, caudate activation was found to track the extent of behavioral adjustments during reward-based learning (Haruno et al. 2004) . Similarly, putamen activation in response to monetary gains predicted behavioral adjustments in trials following reward (Wrase et al. 2007 ). Finally, caudate activation was particularly strong when rewards were unpredictable and participants believed that the outcome was contingent upon their action (Tricomi et al. 2004 ).
Orbitofrontal cortex. A large body of work implicates the OFC in stimulus-reinforcement representations particularly, in flexibly updating such representations to guide adaptive behavior (O'Doherty 2004) . Consistent with this view, OFC lesions in humans lead to perseverative responses in reversal-learning tasks (e.g., Hornak et al. 2004) , and neuroimaging studies have shown that the OFC codes incentive, rather than sensory, features of stimuli across modalities (O'Doherty 2004) .
Functional neuroimaging studies assessing reward processing in MDD. In one of the first fMRI studies directly assessing reward processing in depression, Forbes and coworkers (2006) presented to a pediatric sample a task involving choices linked to varying magnitudes and probabilities of reward and punishment. Compared to controls, depressed children showed reduced activation to rewards in various reward-related regions (e.g., caudate, OFC). In an extension of this work, this group reported that youths with MDD showed reduced anticipatory caudate responses immediately following a winning trial, indicating that reward anticipation was blunted after rewards (Olino et al. 2011) .
Our group used a monetary incentive delay task to investigate neural substrates implicated in anticipation and consumption of monetary gains in depression ). Relative to controls, unmedicated subjects with MDD showed reduced activation in the left nucleus accumbens and bilateral caudate in response to partially unpredictable rewards as well as reduced activation in the left putamen to reward-predicting cues ; see also Stoy et al. 2012) . Reduced putamen activation was also associated with impaired reward-related reversal learning in MDD (Robinson et al. 2012) , and blunted putamen/caudate activation during reward anticipation normalized after antidepressant treatment (Stoy et al. 2012) or psychotherapy (Dichter et al. 2009 ). When seen in the framework of prior studies (e.g., Delgado 2007 , Wrase et al. 2007 ), these findings highlight neural patterns pointing to impaired hedonic coding (NAc), reward-related learning (caudate), and reward prediction (putamen) in MDD.
Direct evidence of neural abnormalities associated with reward-related learning in depression emerged from two elegant studies that combined neuroimaging and mathematical modeling of reward prediction errors. In the first, Steele and coworkers showed that, unlike controls, medicated participants with MDD failed to speed up reaction time and activate ventral striatum regions after receiving positive feedback (Steele et al. 2007) . Notably, lack of reaction time changes after positive (and negative) feedback correlated with anhedonic symptoms. In the second study, the same group investigated neural correlates of reinforcement learning in treatment-resistant subjects with MDD using a Pavlovian reward-learning paradigm, in which abstract pictures were probabilistically associated with the delivery of water (participants were mildly water deprived; Kumar et al. 2008) . Through modeling of reward prediction errors, the authors showed that depressed subjects were characterized by smaller reward-learning signals in the ventral striatum relative to controls. Because reward-learning signals have been strongly implicated in reinforcement learning and goal-directed behavior, these findings provide important information about incentive dysfunction in depression.
Although the findings reviewed above have uncovered blunted striatal activation during reward encoding and reinforcement learning, it is unclear whether such dysfunction relates to affect in daily life. This important issue was addressed in a study that combined fMRI and ecological sampling techniques in adolescents with MDD (Forbes et al. 2009 ). Relative to controls, youngsters with MDD showed weaker caudate activation during the anticipation and outcome of rewards, in line with findings seen in adults ). Notably, blunted caudate activation to both anticipation and consumption of reward correlated with reduced subjective positive affect in natural settings four days before the scan.
HVA: homovanillic acid
Functional neuroimaging studies assessing responses to other appetitive stimuli in MDD. Additional evidence for reduced encoding of incentive cues in depression comes from studies that have described diminished neural responses to positive stimuli (e.g., happy facial expressions, pictures of positive social interaction) in regions implicated in reward processing, such as the ventral striatum (e.g., Epstein et al. 2006) , the caudate (e.g., Elliott et al. 1998) , and the OFC (e.g., Schaefer et al. 2006) . Three sets of additional findings deserve mention. First, reduced reward-related ventral and dorsal striatal activation has been observed in asymptomatic children of parents with MDD as well as in remitted individuals with a history of MDD (Gotlib et al. 2010 , McCabe et al. 2009 , Monk et al. 2008 , consistent with the assumption that blunted encoding of reward-related cues might be associated with increased MDD vulnerability. Second, negative correlations between ventral striatal activation to positive cues and anhedonia have been reported (Epstein et al. 2006 , Keedwell et al. 2005 . Third, deep brain stimulation of the NAc in highly treatment-resistant depressed subjects has antidepressant effects that persist up to four years, highlighting a possible causal link between ventral striatal dysfunction and depression (Bewernick et al. 2012 ).
Interim summary. Across a variety of reward tasks, depression has been associated with blunted activation of striatal regions, and less consistently, of OFC. In light of prior evidence, ventral striatal dysfunctions in MDD might reflect dysfunction in coding the motivational significance of stimuli and updating predictions about expected reward. Caudate dysfunction might be linked to deficient learning of action-reward contingencies, leading to diminished positive reinforcement. Finally, OFC dysfunctions might be associated with impairments in representing the motivational value of stimuli and in updating stimulus-outcome representations. Collectively, these findings suggest that distinct psychological processes and neural abnormalities might contribute to anhedonic phenotypes. Surprisingly, no study has investigated neural correlates associated with decreased recollection of positive cues, underestimation of reinforcements received, or reduced expectation of future rewards. Given evidence for such dysfunction in the behavioral literature reviewed above, future neuroimaging studies should address these important questions.
THE ROLE OF DOPAMINE IN DEPRESSION
Decades of neuroscience research have shown that DA plays a critical role in reinforcement learning (Schultz 1998 ) and incentive motivation (Berridge 2007) . Owing to these findings, interest in the role of DA in the pathophysiology of depression has resurfaced (e.g., Dunlop & Nemeroff 2007) . In particular, possible dysfunctions within mesolimbic DA pathways, which originate from ventral tegmental area neurons and project to the NAc, have attracted substantial attention.
Studies Investigating DA Metabolites
One of the first indications of blunted DA transmission in depression came from reports that subjects with MDD displayed reduced levels of homovanillic acid (HVA), one of the major metabolites of DA, in cerebrospinal fluid (for a recent study, see Mitani et al. 2006) . However, several studies failed to replicate this finding (e.g., Sher et al. 2003) , whereas others reported that reduced HVA levels were present only in patients with melancholic depression (Roy et al. 1985) . One possible reason for these inconsistencies is that lumbar cerebrospinal fluid concentration may not reliably index brain DA. This issue was circumvented by Lambert and coworkers (2000) , who directly measured central nervous system HVA levels through catheters placed in the internal jugular AMPT: α-methylparatyrosine vein. Using this technique, the authors were able to confirm reduced levels of HVA, providing the strongest evidence to date of reduced DA metabolites in depression.
Studies Using DA Depletion or Challenge Paradigms
Evidence of a potential causal link between reduced DA levels and depression comes from studies that acutely lowered DA synthesis through catecholamine depletion. Miller et al. (1996) reported that administration of a tyrosine hydroxylase inhibitor [α-methylparatyrosine (AMPT)] increased depressive (including anhedonic) symptoms in remitted subjects. These findings were replicated by Berman et al. (1999) , who showed that AMPT administration in euthymic subjects with an MDD history led to a transient but marked reinstantiation of depressive symptoms. In addition, AMPT-induced relapse of depressive symptoms was observed in two additional samples with an MDD history (Bremner et al. 2003 , Hasler et al. 2008 .
These findings have been extended by two positron emission tomography (PET) studies, which have shown that DA depletion affects reward-related brain regions. In the first, AMPT-induced increases in depressive symptoms were accompanied by decreased activation in regions receiving strong catecholamine innervations, including the OFC (Bremner et al. 2003) . More recently, Hasler and coworkers (2008) reported that AMPT administration reduced OFC but increased ventral striatal metabolism in both controls and remitted depressed subjects. Interestingly, ventral striatal increases were larger in remitted subjects. Moreover, among the remitted subjects, larger metabolic increases in the ventral striatum were positively correlated with anhedonic symptoms. At first glance this latter finding appears paradoxical, but it can be explained by the fact that, in the striatum, DA inhibits the release of glutamate, the main excitatory transmitter in the brain. Thus, AMPT-induced reduction in DA transmission might have led to disinhibition of striatal regions, resulting in increased PET activation. Accordingly, remitted subjects reporting the strongest anhedonic effects might have had the largest reduction in DA transmission.
Similar findings emerged from a study in which administration of dextroamphetamine (a psychostimulant that induces DA release) was used to probe reward pathways in MDD. After receiving dextroamphetamine, subjects with MDD displayed reduced activation in various reward-related brain regions (OFC, caudate, and putamen) in response to pleasant pictures (Tremblay et al. 2005) . Behaviorally, subjects with MDD also showed potentiated affective responses (e.g., euphoria) to dextroamphetamine (Tremblay et al. 2002 (Tremblay et al. , 2005 . Interestingly, the rewarding effects of the DA agonist were largest in anhedonic subjects (Tremblay et al. 2002) . Findings of increased hedonic responses and reduced activation in reward-related brain areas in response to dextroamphetamine can be explained by the DA-glutamate interactions mentioned above. Thus, DA release after dextroamphetamine might have inhibited glutamate in striatal regions, resulting in decreased striatal activation and fMRI signals. Both the behavioral and fMRI findings were interpreted as reflecting a hypofunctional reward system in MDD.
Although findings reviewed thus far suggest that MDD is characterized by reduced DA synthesis, the interpretation is complicated by null findings that AMPT administration did not modulate depressive symptoms in currently depressed, drug-free subjects (Berman et al. 2002 , Miller et al. 1996 and by the fact that AMPT depletes both DA and norepinephrine. Although the lack of findings in currently depressed subjects might be explained by floor effects, acute lowering of DA synthesis through administration of an amino acid mixture lacking DA precursors (phenylalanine and/or tyrosine) did not worsen depressive symptoms in two remitted depressed samples (McTavish et al. 2005 , Roiser et al. 2005 . Interestingly, DA depletion significantly reduced betting in a gambling task in the remitted sample (Roiser et al. 2005) , indicating that behavioral manifestation of reduced reward responsiveness can emerge in the absence of self-reported effects.
DAT: dopamine transporter
Molecular Imaging Studies
Findings from imaging studies using radioactive tracers to probe putative DA dysfunctions in MDD have not painted a coherent picture. However, some evidence consistent with reduced DA tone has emerged in the form of reduced dopamine transporter (DAT) density and increased density of D2 postsynaptic receptors.
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Increased D2 receptor density in depression? Early studies using single-photon emission computerized tomography in conjunction with the [ 123 I]-IBZM tracer described increased striatal D2 binding in MDD (e.g., Shah et al. 1997) , a finding suggesting possible compensatory up-regulation of D2 receptors due to low DA transmission. However, other studies failed to replicate this finding (e.g., Ebert et al. 1996) , raising the possibility that clinical heterogeneity might contribute to these inconsistencies. In line with this, Ebert et al. (1996) found that increased D2 binding was restricted to patients with psychomotor retardation, whereas D2 receptor up-regulation was reduced in patients responding to pharmacology. Similarly, reduced striatal D2 binding was found in recovered depressed subjects treated with selective serotonin reuptake inhibitors, suggesting that remission may be linked to increased endogenous DA release and/or reduced D2 receptor expression (Montgomery et al. 2007 ).
Decreased DAT density in depression?
Studies assessing DAT density in MDD have yielded similarly inconsistent findings, with some studies describing down-regulation of DAT densities (e.g., Sarchiapone et al. 2006 ) and others describing opposite results (e.g., Brunswick et al. 2003) . These inconsistencies might reflect the fact that these studies have used tracers (e.g., β-CIT) that have similar affinities for the DAT and serotonin transporter, which complicates interpretations. In contrast, postmortem studies have provided compelling evidence of reduced DAT levels in striatal regions (caudate, putamen, NAc) of depressed subjects (Bowden et al. 1997 , Klimek et al. 2002 .
Interim summary.
Investigations of possible DA dysfunction in MDD have received renewed interest. Findings emerging from studies assessing DA metabolites as well as studies utilizing DA depletion paradigms or neuroimaging techniques converge in suggesting reduced DA transmission in depression. In neuroimaging studies, the most replicated finding is decreased DAT binding, a dysfunction that can be explained by blunted endogenous DA transmission. Despite these results, it is important to emphasize that direct evidence of reduced DA release, particularly during reward tasks, is missing. When seen within the framework of prior animal studies, disruption of DA signaling can explain behavioral findings of abnormal prediction errors and blunted reinforcement learning in MDD (Kumar et al. 2008 , Pizzagalli et al. 2008b ).
THE ROLE OF STRESS IN DEPRESSION
The role of stress in the development, expression, and exacerbation of depression is well established (Brown & Harris 1978) . In community samples, up to 80% of major depressive episodes (MDEs) are preceded by major life events, particularly in the one to three months before MDE onset, and it has been estimated that stressors are approximately 2.5 times more frequent in the period before an MDE relative to a comparable period in controls (Hammen 2005 , Mazure 1998 ). In addition, chronic stressors have been linked to poorer prognosis and more frequent relapse (e.g., Lethbridge & Allen 2008) , symptom deterioration following therapy (Hawley et al. 2007 ), treatment resistance (Amital et al. 2008) , and higher depressive symptoms in both depressed and remitted samples (Leskela et al. 2006) . Several recent reviews have summarized links between stress and depression (e.g., Hammen 2005) , so the goal of the following section is not to provide an exhaustive summary. Instead, we highlight selected findings that have contributed to a more nuanced understanding of stress-depression links and are particularly relevant to the theoretical integration presented here.
First, although severe stressors have been generally linked to increased risk of depression, chronic stressors and events characterized by perceived (a) lack of control, (b) inability to escape or resolve the aversive situation (e.g., entrapment), or (c) loss of status (e.g., humiliation) appear to be particularly depressogenic (e.g., Brown & Harris 1978 , Kendler et al. 2003 . Findings emphasizing the uncontrollability component of stressors are consistent with data indicating that perceived control over stressors is a key modulator of physiological stress responses (Dickerson & Kemeny 2004) . Notably, Haeffel et al. (2008) reported that stressors interacted with a cognitive vulnerability (negative inferential style) to predict decreases in self-reported goal-directed behavior and that this effect was mediated by hopelessness. This suggests that in an ongoing stressful situation, perceived lack of control may interact with the expectation that a desired outcome will not occur and as a result will shut down goal-directed behavior.
Second, stressors play a stronger role in triggering first episodes of depression than recurrences (e.g., Daley et al. 2000) , and the association between stressors and depression becomes weaker with increasing number of episodes (Kendler et al. 2000) . These findings have been interpreted as supporting the "kindling/sensitization" theory proposed by Post (1992), which postulates that neurobiological changes occurring in response to depression and stress might "sensitize" individuals and thus increase risk for future depressive episodes in the absence of stressors. Results of the animal literature reviewed in the next section indicate that future studies should investigate whether dysfunctions within mesocortical and mesolimbic DA pathways contribute to these sensitization effects.
Finally, individuals with stress-sensitized systems (e.g., individuals exposed to early adversity or with recurrent MDD) appear to be particularly affected by minor stressors later in life. For example, MDEs were triggered by smaller amounts of stress in children or adolescents exposed to early childhood adversities compared to youngsters without such histories (e.g., Hammen et al. 2000) . In addition, retrospective (e.g., Gladstone et al. 1999 ) and prospective (Widom et al. 2007 ) studies reveal that early adversities (e.g., physical abuse and neglect) not only increase rates of depression but also accelerate the emergence of depression. Interestingly, severe childhood adversities have been associated with higher rates of anhedonic symptoms (Lumley & Harkness 2007) .
Interim summary. Severe stressors, particularly those deemed uncontrollable and inescapable, play an important etiological role in depression, especially for first episodes. With increasing numbers of MDEs, the link between stress and depression becomes weaker, arguably due to kindling/sensitization processes that increase vulnerability to future episodes. Initial evidence indicates that such processes might be potentiated in individuals with a history of early adversity, which has been linked to the emergence of anhedonic symptoms. As is discussed in the next section, these data show intriguing parallels with animal models of depression, in which chronic uncontrollable stressors induce anhedonic-like behavior and profound dysfunction within brain reward pathways.
Ventral tegmental area Nucleus accumbens Prefrontal cortex
Cingulate gyrus Striatum Substantia nigra
Figure 3
A schematic illustration of mesocortical and mesolimbic dopamine (DA) pathways. The diagram shows DA nuclei within the ventral tegmental area projecting to the nucleus accumbens and prefrontal cortex, and within the substantia nigra projecting to the dorsal striatum (caudate and putamen). 
THE EFFECTS OF STRESS ON DOPAMINERGIC PATHWAYS
The vast majority of cell bodies producing DA can be found in various nuclei in the midbrain, including the retro-rubro field, the substantia nigra pars compacta, and the ventral tegmental area (VTA). DA-producing neurons in the VTA innervate the mesocortical and mesolimbic DA pathways, which are particularly relevant to the topic of the present review. Originating from the VTA, the mesocortical pathway primarily projects to the prefrontal and anterior cingulate cortex (Figure 3) and plays an important role in executive function. The mesolimbic pathways originate from the VTA but project mostly to ventral striatal regions (particularly the NAc), the amygdala, and the hippocampus, among other regions (Figure 3) . Functionally, the mesolimbic DA pathway has been implicated in incentive motivation and reinforcement learning. Moreover, a variety of findings indicate that DA might be particularly important for coding the incentive salience ("wanting"), rather than hedonic aspects ("liking"), of stimuli and might thus encode motivational aspects of rewards (Berridge 2007) . In the following sections, the effects of acute and chronic stressors on mesolimbic and mesocortical DA pathways are reviewed.
The Effects of Acute Stressors on Motivated Behavior and Dopaminergic Transmission
Over several decades, a multitude of animal studies have shown that acute mild stressors (e.g., foot shock, physical restraint) quickly and robustly activate mesocortical DA neurons, leading to a substantial increase in DA levels in the medial prefrontal cortex (mPFC) (e.g., Abercrombie et al. 1989) . If animals are exposed to more severe and sustained stressors, increased DA levels are also observed in mesolimbic pathways, particularly the NAc (Cabib & Puglisi-Allegra 2012) .
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Interestingly, stress-induced DA release starts earlier and is larger in the mPFC (95% increase of DA outflow) than in the NAc (39% increase) or striatum (25% increase) (Abercrombie et al. 1989 , Chrapusta et al. 1997 . Behaviorally, enhanced mesolimbic DA release in the face of acute stressors has been found to promote behavioral activation and active coping (Cabib & Puglisi-Allegra 2012) . Of note, the mesocortical and mesolimbic DA systems respond in opposite ways when animals face inescapable or uncontrollable acute stressors. In the NAc, inhibition of mesolimbic DA release has been described when animals face sustained uncontrollable and inescapable stressors and show behavioral evidence of coping failures (Cabib & Puglisi-Allegra 2012 , Rossetti et al. 1993 . In an early rat study, for example, Imperato and coworkers (1992) reported that acute restraint stress led to increased extracellular DA in the NAc in the first three days of testing, whereas no DA responses were seen after the fourth day. These findings contrast with observations of increased DA release in the NAc in response to short, novel, and/or controllable aversive conditions (Chrapusta et al. 1997) . Altogether, these findings indicate that blunting in mesolimbic DA release is associated with coping failure, including learned helplessness and behavioral despair (Cabib & Puglisi-Allegra 2012) . Notably, antidepressant administration before exposure to uncontrollable stress prevented mesolimbic DA depletion (Rossetti et al. 1993) .
Exposure to an inescapable stressor generally results in higher mPFC DA release compared to exposure to an escapable stressor of identical intensity and duration (Cuadra et al. 1999) . Furthermore, prior exposure to chronic stress amplifies the response of mesocortical DA neurons in response to a subsequent acute stressor, highlighting possible sensitization effects consistent with the kindling hypothesis (Post 1992). Because DA exerts inhibitory effects on mPFC function, DA release in the mPFC in the face of uncontrollable stressors may reduce mPFC-mediated behavior, including regulation of the hypothalamic-pituitary-adrenal axis (Maier et al. 2006 ). In addition, because PFC DA transmission exerts a regulatory (inhibitory) control over DA activity in the NAc (e.g., Del Arco & Mora 2008) , potentiated stress-related responses in the mesocortical DA system are expected to blunt DA release in mesolimbic pathways and maintain depression-like behavior.
Consistent with this hypothesis, when exposed to acute stressors, an inbred line of rats displaying elevated levels of despair showed rapid activation of the mesocortical DA system and concurrent inhibition of the mesolimbic DA system . Notably, in this susceptible strain, depletion of mesocortical DA as well as chronic administration of antidepressants reversed the stress-induced mesolimbic inhibition and eliminated stress-induced despair behavior . On the basis of these findings, the authors proposed that vulnerability to depression might involve a susceptibility to "stress-induced activation of [the] mesocortical DA system leading to inhibition of the mesolimbic DA system" (Ventura et al. 2002, p. 999) . 
The Effects of Chronic Stressors on Motivated Behavior and Dopaminergic Transmission
Behavioral and physiological effects. On the basis of the observation that early adversities and chronic stressors increase vulnerability to depression in humans (see prior section), basic CMS: chronic mild stress scientists interested in animal models of depression soon started investigating behavioral and neurobiological sequelae of prolonged exposure to stressors. Katz (1982) was among the first to develop a stress-induced animal model of depression, in which rats were subjected to various severe stressors for a period of three weeks. Notably, chronically stressed animals decreased intake of palatable solutions, suggesting a possible decreased sensitivity to reward.
This approach was subsequently modified by Willner, who developed the chronic mild stress (CMS) model, in which animals are exposed to a variety of relatively mild stressors over a prolonged period of time (Willner 2005) . A multitude of rodent studies have shown that exposure to a CMS leads to (a) decreased intake of and preference for palatable liquids (e.g., Bekris et al. 2005) , which can last one month after stress termination (Elizalde et al. 2008 ); (b) reduced place-preference conditioning (i.e., reduced approach to a place previously paired with a reward; Papp et al. 1991) ; (c) increased threshold for brain stimulation reward in the VTA (Moreau et al. 1992 ); (d ) reduced DA release in the NAc in response to palatable food (Di Chiara et al. 1999) ; and (e) reduced basal striatal DA activity but increased basal PFC DA activity (e.g., Bekris et al. 2005 .
In rats, CMS exposure potentiated decreases in sucrose preference elicited by a later stressor (restraint), raising the possibility that early exposure to uncontrollable stressors increases vulnerability for developing anhedonia after encountering novel stressors (Zurita et al. 2000) . Highlighting promising validity, CMS-induced anhedonic-like symptoms and accumbens DA blunting could be reversed (e.g., Bekris et al. 2005 , Elizalde et al. 2008 or prevented (e.g., Di Chiara et al. 1999) by antidepressant pretreatment.
In addition to the CMS model, anhedonic-like behavior and decreased motivation have emerged in other paradigms involving chronic stressors. Prolonged restraint stress, for example, has been associated with a 50% reduction in motivated behavior in an appetitive operant conditioning paradigm (Kleen et al. 2006) . In a particularly innovative study, stress-induced anhedonia was greater, appeared earlier, and lasted longer in rats with a (pre-stress) pessimistic rather than optimistic trait, which was operationalized as the tendency to respond to an ambiguous tone with physical properties in-between tones previously associated with a negative (electric shock) versus positive (food pellet) outcome, respectively (Rygula et al. 2013) .
Along similar lines, sustained postnatal deprivation and maternal separation produced adult phenotypes characterized by reduced (a) motivation to obtain sucrose reward , (b) social motivation (Mintz et al. 2005) , and (c) acquisition and expression of Pavlovian appetitive conditioning (Matthews & Robbins 2003) . Notably, Pryce and coworkers (2004) found that adult monkeys subjected to early maternal separation displayed diminished motivation to obtain a reward despite normative consummatory behavior. These findings fit prior reports indicating that administration of DA antagonists reduces approach motivation without affecting consumption (Pfaus & Phillips 1991) and with theories emphasizing the role of DA in incentive motivation ("wanting"; Berridge 2007) .
Chronic social stress (typically induced by chronic social isolation or a resident-intruder paradigm leading to social defeat) also produced behavioral indices of anhedonia (diminished preference for sucrose solution) and motivational deficits (decreased exploratory behavior) (e.g., Grippo et al. 2007 , Rygula et al. 2008 . In rats, social defeat followed by isolation reduced anticipatory behavior for up to three months postdefeat (Von Frijtag et al. 2000) . Notably, postdefeat social housing (Von Frijtag et al. 2000) as well as antidepressant treatment (Rygula et al. 2008) abolished anticipatory reward deficits of socially defeated animals. Similarly, three months of Pavlovian behavioral training involving receipt of a predictable reward restored anticipatory responses to a sucrose reward in rats that had previously been exposed to social defeat and isolation (van der Harst et al. 2005 ).
Long-term neurobiological effects. Physiologically, prolonged exposure to chronic unavoidable stressors leads to three abnormalities that are particularly relevant to this review: (a) downregulation of mesolimbic DA pathways, (b) reduced DAT levels, and (c) sensitization of mesocortical DA responses to novel stressors.
First, a large body of work indicates that chronic stressors lead to profound and long-lasting changes within mesolimbic DA pathways (Cabib & Puglisi-Allegra 2012) . For example, chronic unavoidable stressors produced a 64% reduction in the number of spontaneously active DA neurons in the VTA (Moore et al. 2001 ) and reduced DA output in the NAc up to 14 days poststress (Gambarana et al. 1999) . Notably, stress-induced reduction in DA transmission has been observed in the shell of the NAc (a subregion primarily involved in motivational processes), and reduction in mesolimbic DA was closely related to coping failures (e.g., escape deficit) and maintenance of depression-like behaviors; such blunting was normalized by antidepressant treatment .
Second, prolonged exposure to chronic stressors results in decreased DAT levels along mesoaccumbens DA pathways, a marker indicative of blunted mesolimbic DA release. Specifically, reduced DAT has been observed in the NAc, caudate, or putamen of adult animals exposed to (a) early maternal separation (Brake et al. 2004 ), (b) chronic psychosocial stress (Isovich et al. 2000 , Lucas et al. 2004 , and (c) prolonged immobilization stress (Lucas et al. 2007 ). Intriguingly, as reviewed in the section on the role of DA in depression, lowered DAT binding has been described in MDD patients (Bowden et al. 1997 , Klimek et al. 2002 . Reduced DAT has been also observed in rats bred for increased vulnerability to depression-like behavior and in those displaying reduced motivation for reinforcements (e.g., Jiao et al. 2003) , strengthening the hypothesis that DA dysfunctions play an important role in the pathophysiology of depression.
Of note, reduced DAT in the NAc of chronically stressed animals was observed three weeks after stress termination (Lucas et al. 2004) . Conversely, successful acquisition of appetitive behavior, which had been previously shown to induce DA in the NAc , prevented stress-induced DAT reductions (Nanni et al. 2003) . These latter findings are particularly important because they show that acquisition of appetitive behavior can partially protect against the deleterious effects of later stressors on DAT function, and they highlight an intriguing parallel to data on the efficacy of behavioral activation treatments for depression (Ekers et al. 2008) . Of note, mice that did not succumb to a psychosocial stressor (i.e., did not show decreased sucrose consumption after social defeat) were characterized by increased plasticity and gene expression within the VTA and NAc (Krishnan et al. 2007) . Moreover, in socially isolated rats, DA concentration in the ventral striatum was positively correlated with sucrose intake (Brenes & Fornaguera 2008) . Together, these findings are consistent with the hypothesis that a stable and responsive brain reward system might characterize resilience (Southwick et al. 2005) .
Third, various findings indicate that prior exposure to chronic stress sensitizes mesocortical DA response to novel stressors. Thus, chronically stressed rats show a potentiated mPFC DA release in response to a later stressor (Cuadra et al. 1999) . Sensitized DA response in the PFC (but reduced NAc release) was also seen in rats exposed to an acute stressor 14 days after termination of chronic stress (Chrapusta et al. 1997) . Because mesocortical DA neurons are hypothesized to inhibit responses of DA terminals in the NAc (King et al. 1997) , this stress-induced sensitization of mesocortical DA neurons might contribute to the maintenance of anhedonic behavior.
Interim summary. Decades of animal research have shown that early adverse events (e.g., maternal separation) as well as prolonged exposure to uncontrollable stressors lead to a down-regulation of mesolimbic DA pathways and reduced responsiveness to rewarding stimuli. In light of (a) robust links between stress and depression (see section The Role of Stress in Depression), (b) evidence of DA dysfunction in depression (see section The Role of Dopamine in Depression), and (c) data highlighting a key role of phasic DA responses in the acquisition and expression of motivated behavior (this section), these preclinical findings suggest that dysfunctions in mesolimbic DA pathways might subserve disrupted positive reinforcement learning and lack of reactivity to pleasurable stimuli seen in depression. As elaborated in more detail below, these data also raise the possibility that the well-established link between stress and depression might be partially mediated by the emergence of anhedonic phenotypes.
Of primary relevance to depression research however, this preclinical work has clearly shown that these behavioral and physiological effects are dependent on the nature of the stressor (uncontrollable versus controllable), early experiences (normal versus adverse rearing environments), genetic make-up (Cabib & Puglisi-Allegra 2012 , and preexisting cognitive biases (Rygula et al. 2013) . The ability of an organism to exert control over a stressful situation, in particular, has been found to have profound effects on biological and behavioral processes. This feature parallels clinical literature in which the individual's appraisal of his/her ability to cope with a stressor moderates depressogenic effects (see section The Role of Stress in Depression).
ARE DEPRESSION AND ANHEDONIA PATHOLOGICAL CONDITIONS ARISING FROM DYSFUNCTIONAL INTERACTIONS BETWEEN STRESS AND THE BRAIN REWARD SYSTEM? A SYNTHESIS
The main goals of the present review are twofold. The first goal is to review three large bodies of literature that have emphasized the prominent roles of anhedonia, DA, and stress in depression. More importantly, in light of the fact that these three fields of inquiry have evolved largely independently from each other, the second goal is to integrate these literatures and advance the hypothesis that depression and anhedonia are pathological conditions arising from dysfunctional interactions between stress and the brain reward system. To this end, we review a fourth body of preclinical work that convincingly shows that chronic, uncontrollable stressors induce an anhedonic phenotype as well as profound and long-lasting neurobiological changes within mesocortical and mesolimbic pathways. Because these animal data are rarely considered in clinical science, we identify several similarities between human and preclinical findings, cognizant of the limitations of translating animal findings to humans. On the basis of this convergence, we propose that stress induces anhedonic behavior by causing dysfunction in mesolimbic DA pathways implicated in incentive motivation and reinforcement learning; stress-induced anhedonia may, in turn, strengthen the relationship between stress and depression. In the next sections, empirical data supporting this proposition in humans are presented, followed by a discussion of future directions.
Several sets of findings provide correlational evidence in favor of links among stress, DA, and depression in humans. First, the melancholic subtype of depression, in which anhedonia plays a key role (APA 2000) , has been associated with both hypercortisolemia (Gold & Chrousos 1999) and increased perceived severity of stressors (Willner et al. 1990) . Second, individuals with elevated anhedonic symptoms reported higher perceived stress relative to controls despite similar exposure to stressors (Horan et al. 2007) . Along similar lines, we found that subjects appraising their life as being unpredictable, uncontrollable, and overwhelming showed decreased reward responsiveness (Pizzagalli et al. 2007) . A recent study using experience sampling procedures further extended these findings by showing that subjects with MDD were characterized by increased stress sensitivity and reduced reward experience (Wichers et al. 2008) . Antidepressant treatment normalized both effects. Interestingly, increased reward experience-but not reduction in stress sensitivity-from baseline to week six predicted treatment response, suggesting that normalization of hedonic capacity is key for fostering symptom remission.
These correlational findings have been complemented by three sets of data that have provided important evidence that stressors can indeed decrease hedonic capacity and/or reward responsiveness in humans. First, both acute (Al'Absi et al. 2012 ) and chronic (Berenbaum & Connelly 1993 ) stress reduced self-reported ratings of pleasure. Notably, these effects were largest in individuals reporting a familial history of depression (Berenbaum & Connelly 1993) , suggesting that stress-induced hedonic blunting may be strongest in individuals at increased risk for depression. Second, both acute laboratory (Bogdan & Pizzagalli 2006 , Bogdan et al. 2011 ; Figure 2b ) and naturalistic (Nikolova et al. 2012 ) stressors reduced participants' ability to modulate behavior as a function of rewards, providing important empirical evidence that stress reduces reinforcement learning. Interestingly, stress-induced reductions in reward responsiveness were largest in individuals with elevated anhedonic symptoms (Bogdan & Pizzagalli 2006) or carrying variants of the corticotropin-releasing hormone type 1 receptor gene previously linked to stress regulation (Bogdan et al. 2011) . When seen within the framework of preclinical evidence, these findings indicate that both objective stressors and perceived lack of control over stressors might reduce hedonic capacity and reinforcement learning. Whether these behavioral effects are accompanied by perturbation within mesolimbic and mesocortical DA pathways remains to be tested.
Finally, recent findings indicate that early adversities are associated with behavioral and neural evidence of reduced reward processing. In a sample of depressed adolescents, childhood maltreatment correlated with adult anhedonic symptoms (Lumley & Harkness 2007) , and this link was mediated by themes of loss and worthlessness. In a "wheel-of-fortune" task, maltreated children with depressive disorders showed a conservative decision-making strategy during high-risk trials (Guyer et al. 2006) . We extended these findings by showing that (a) women with a history of MDD and childhood maltreatment were characterized by neural and behavioral deficits in utilizing previous reinforcement to optimize decision making , and (b) euthymic young adults with a history of childhood adversity showed blunted striatal activation during reward-but not penalty-anticipation ). This selective dysfunction was hypothesized a priori owing to preclinical data indicating that (a) early adverse events have long-lasting effects on mesolimbic DA pathways , Pryce et al. 2004 ) and (b) DA has been primarily implicated in the anticipatory phase ("wanting") rather than consummatory phase ("liking") of reward processing (Berridge 2007) .
In sum, multiple lines of evidence converge to suggest that both chronic stressors and early childhood adversities might increase the risk for depression by reducing hedonic capacity, incentive motivation, and reinforcement learning, providing promising leads for therapeutic interventions. Whether these deficits in humans are associated with a reduction in mesolimbic DA signaling, however, remains unknown. In an initial attempt to elucidate this relationship, we performed a pharmacological challenge study in psychiatrically healthy subjects and found that the administration of a single low dose of a D2/D3 agonist (pramipexole), which is hypothesized to decrease phasic DA due to presynaptic autoreceptor activation, reduced reward responsiveness (Figure 2c ; Pizzagalli et al. 2008a ). Critically, this blunted reward responsiveness was qualitatively similar to the pattern observed in both unmedicated subjects with MDD (Pizzagalli et al. 2008b ; Figure 2a ) and healthy controls under acute stress (Bogdan & Pizzagalli 2006 ; Figure 2b) , providing promising convergence. We expect that similar pharmacological challenges in both controls and subjects with MDD, particularly when combined with functional neuroimaging and computational modeling (e.g., Kumar et al. 2008) , will provide important insights into mechanisms underlying blunted hedonic behaviors and incentive motivation in depression.
FUTURE DIRECTIONS AND CAVEATS
Several questions concerning the etiology and pathophysiology of depression remain unanswered and require further attention. First, with the exception of few recent studies describing reduced reward-related striatal (NAc, putamen) and OFC activation in individuals at increased risk for depression (offspring of parents with MDD; Gotlib et al. 2010 , McCabe et al. 2012 , Monk et al. 2008 , most neuroimaging studies have investigated symptomatic subjects during an MDE. Along similar lines, although reduced DAT density might arise as a compensatory mechanism linked to reduced DA transmission, no studies can exclude the alternative hypothesis that decreased DAT levels constitute the primary abnormality that increases MDD vulnerability. Consequently, studies investigating at-risk samples (before the onset of the first MDE), including monozygotic twins discordant for depression and individuals with cognitive vulnerability or who carry genetic variants associated with increased depression liability, will be needed to investigate whether striatal or DAT dysfunctions are a consequence or cause of MDD.
Second, although evidence indicates that behavioral activation treatments are effective in alleviating depressive symptoms (Ekers et al. 2008) , it is currently unknown whether such treatment might be particularly useful for subjects with MDD characterized by reinforcement learning deficits and/or mesolimbic DA blunting. Such knowledge is important for moving us closer to personalized treatments.
Third, with the exception of a few recent attempts aimed at parsing distinct components of reward processing in MDD (e.g., Pizzagalli et al. 2008b , Sherdell et al. 2012 , Treadway et al. 2012 , little attention has been devoted to investigating the possibility that anhedonia is psychologically and neurobiologically complex. Identifying environmental and biological factors associated with different manifestations of anhedonia might enrich our understanding of the etiology and pathophysiology of depressive phenotypes.
Fourth, in spite of the focus in this review on mesocorticolimbic DA pathways, depression has been clearly associated with dysfunction in other key regions implicated in affect and emotion regulation, including the PFC, amygdala, and hippocampus (Pizzagalli & Treadway 2014) . Although a summary of this literature is beyond the scope of this review, it is important to emphasize that these regions have been implicated in the regulation of stress responses and coping, albeit in different ways. Thus, whereas the mPFC and hippocampus provide inhibitory control over stress responses, the amygdala has been implicated in potentiating stress responses (Diorio et al. 1993) . Elegant work by Maier and coworkers, in particular, has shown that detection of control within a stressful situation activates the mPFC, which in turn inhibits stress-induced activation of brainstem and limbic regions (Maier et al. 2006) . Intriguingly, experience of stress controllability has been found to modify mPFC responses to future uncontrollable stressors, which might contribute to increases in resilience. Based on this evidence, we hypothesize that in MDD, mPFC, hippocampal, and amygdala dysregulation is associated with increased stress responsiveness (Figure 1) .
Fifth, despite compelling evidence that stressors have profound effects on mesocorticolimbic DA pathways, it is not immediately clear how specific this link is. Is DA particularly susceptible to the deleterious effects of stressors, especially uncontrollable ones? Or are other neurotransmitters equally affected by such perturbations, with the emphasis on DA simply the consequence of a strong focus on reward processing?
Finally, although we emphasize the effects of chronic stressors, including early rearing environments, on reward processing and mesolimbic DA pathways in both the animal and human literature, it is clear that such stressors have long-lasting effects on other processes, including enhanced perceptual sensitivity to threat-related cues, exaggerated hypothalamic-pituitary-adrenal responses, and hippocampal dysfunction (for a review, see Pechtel & Pizzagalli 2011 ). Future human research should pay particular attention to the role of epigenetic effects 4 in increasing risk for MDD, especially in the context of early adversity. Seminal work by Meaney, Turecki, and others has shown that low levels of maternal care and chronic stress in rodents were associated with adult phenotypes characterized by potentiated behavioral and endocrinological responses to stress, reduced appetitive behavior, and increased vulnerability to stress-induced learned helplessness (for reviews, see Lutz & Turecki 2013 , Zhang et al. 2013 . Critically, these phenotypes were associated with increased methylation of the promoter region of the glucocorticoid receptor gene in hippocampal neurons, which in turn reduced gene expression and thus the number of glucocorticoid receptors in the hippocampus. These alterations ultimately resulted in blunted glucocorticoid negative feedback sensitivity and exaggerated corticotrophin-releasing factor levels. Initial findings of increased DNA methylation in the hippocampus of suicide victims with a history of childhood adversity (Labonté et al. 2012 , McGowan et al. 2009 ) as well as evidence of methylation in the promoter region of the glucocorticoid receptor gene in volunteers reporting childhood maltreatment (Tyrka et al. 2012) suggest that similar processes might occur in humans. Collectively, this emerging evidence indicates that epigenetic-mediated alterations in the expression of genes implicated in stress regulation could be a mechanism through which the environment can confer increased vulnerability to MDD. Clearly, these mechanisms deserve further scrutiny, since they might open important avenues for prevention.
CONCLUSION
In conclusion, depression is etiologically and pathophysiologically complex and heterogeneous. In the present review, we focus on a promising endophenotype of depression-anhedonia-and propose that this cardinal symptom of and risk factor for depression might arise as a result of the detrimental effects of stressors on mesocorticolimbic DA pathways. Although limited by a focus on anhedonia, the present review proposes a working model that makes precise hypotheses about behavioral (e.g., decreased reward encoding and reinforcement learning), neurochemical (e.g., blunted mesolimbic DA transmission), and neurobiological (e.g., functional and structural striatal dysfunctions) abnormalities that might characterize links between stress and depression. We expect that approaches focusing on intermediate depressive phenotypes will help overcome the limitations of current classification systems, will propel the field toward a better understanding of this debilitating disease, and will facilitate the development of much-needed prevention and treatment approaches.
DISCLOSURE STATEMENT
Over the past three years, D.A. Pizzagalli has received consulting fees from ANT (Advanced Neuro Technology) North America, AstraZeneca, Shire, Servier, and Ono Pharma USA as well as honoraria from AstraZeneca, all for projects unrelated to the present review. The author is not aware of any affiliations, memberships, funding, or financial holdings that might be perceived as affecting the objectivity of this review.
